Predicting the Risk for Pathological Fracture in Bone Metastases.
Approximately 50–70% of patients with advanced cancer will experience bone metastases. The link between metastatic lesions and pathological bones is especially troubling since more metastases mean a higher chance of painful fractures, which can reduce mobility and often require surgery. Therefore, f...
| Publicado en: | Current Oncology Vol. 32; no. 6; pp. 309 - 318 |
|---|---|
| Autores principales: | , , , , |
| Formato: | Journal Article |
| Publicado: |
MDPI
Jun2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=186205471&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 186205471 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 11980052 5EKK jtl: Current Oncology issn: 11980052 maglogo: N pubinfo: dt: Jun2025 vid: 32 iid: 6 pid: 97109 pub: MDPI artinfo: ui: 186205471 10.3390/curroncol32060309 186205471 ppf: 309 ppct: 9 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Predicting the Risk for Pathological Fracture in Bone Metastases. aug: au: Altsitzioglou, Pavlos Tsukamoto, Shinji Errani, Costantino Tanaka, Yasuhito Mavrogenis, Andreas F. affil: First Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, 15562 Athens, Greece sug: ab: Approximately 50–70% of patients with advanced cancer will experience bone metastases. The link between metastatic lesions and pathological bones is especially troubling since more metastases mean a higher chance of painful fractures, which can reduce mobility and often require surgery. Therefore, fracture risk predictions are essential for managing patients with bone metastases. However, the current methods for evaluating the risk of fractures are subjective, with low predictive value. This paper highlights how there being no effective comprehensive models for grouping patients by fracture risk due to skeletal metastases makes it harder to create personalized treatment plans; presents the methods currently used for objective evaluations of the pathological fracture risk in bone metastases; and discusses their pros and cons. pubtype: Academic Journal doctype: Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|